Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFFP
4051
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $200K | ﹤0.01% |
+7,602
| New | +$200K |
|
4052
Cars.com
CARS
$822M
| $197K | ﹤0.01% |
14,309
-12,836
| -47% | -$177K |
|
4053
Cardiff Oncology
CRDF
$136M
| $197K | ﹤0.01% |
140,767
-59,020
| -30% | -$82.6K |
|
4054
GoHealth
GOCO
$75.3M
| $197K | ﹤0.01% |
18,887
-4,474
| -19% | -$46.7K |
|
|
TVRD
4055
Tvardi Therapeutics
TVRD
$359M
| $197K | ﹤0.01% |
+509
| New | +$197K |
|
4056
European Wax Center
EWCZ
$173M
| $196K | ﹤0.01% |
15,705
+2,046
| +15% | +$25.5K |
|
4057
Identive
INVE
$88.2M
| $196K | ﹤0.01% |
+27,113
| New | +$196K |
|
|
RVLP
4058
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $195K | ﹤0.01% |
173,947
+11,719
| +7% | +$13.1K |
|
|
MACK
4059
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $195K | ﹤0.01% |
+16,985
| New | +$195K |
|
4060
Regis Corp
RGS
$68.9M
| $192K | ﹤0.01% |
7,885
-3,572
| -31% | -$87K |
|
4061
PennantPark Floating Rate Capital
PFLT
$970M
| $191K | ﹤0.01% |
17,404
-6,748
| -28% | -$74.1K |
|
4062
Clearwater Analytics
CWAN
$5.33B
| $190K | ﹤0.01% |
+10,112
| New | +$190K |
|
4063
TOP Financial Group
TOP
$54.9M
| $189K | ﹤0.01% |
+38,761
| New | +$189K |
|
|
CKPT
4064
DELISTED
Checkpoint Therapeutics
CKPT
| $188K | ﹤0.01% |
36,878
-18,301
| -33% | -$93.3K |
|
4065
Outlook Therapeutics
OTLK
$42.8M
| $188K | ﹤0.01% |
8,710
+2,068
| +31% | +$44.6K |
|
|
ACR
4066
ACRES Commercial Realty
ACR
$156M
| $186K | ﹤0.01% |
+22,536
| New | +$186K |
|
4067
Burford Capital
BUR
$2.72B
| $186K | ﹤0.01% |
22,850
+10,855
| +90% | +$88.4K |
|
|
CGRN
4068
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $186K | ﹤0.01% |
127,989
+84,526
| +194% | +$123K |
|
4069
Kaltura
KLTR
$258M
| $185K | ﹤0.01% |
107,699
+80,036
| +289% | +$137K |
|
4070
China Yuchai International
CYD
$1.5B
| $183K | ﹤0.01% |
+25,809
| New | +$183K |
|
4071
XBiotech
XBIT
$82.9M
| $183K | ﹤0.01% |
52,244
-85,743
| -62% | -$300K |
|
4072
Cipher Mining
CIFR
$4.83B
| $182K | ﹤0.01% |
+325,760
| New | +$182K |
|
4073
BioCryst Pharmaceuticals
BCRX
$1.62B
| $181K | ﹤0.01% |
15,791
-1,310,651
| -99% | -$15M |
|
4074
Genco Shipping & Trading
GNK
$804M
| $181K | ﹤0.01% |
11,803
-24,437
| -67% | -$375K |
|
|
TDCX
4075
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $181K | ﹤0.01% |
14,637
-189,634
| -93% | -$2.34M |
|